Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
IEEE ... International Conference on Rehabilitation Robotics : [Proceedings]|August 4, 2019
Co-Ex: A Torque-Controllable Lower Body Exoskeleton for Dependable Human-Robot Co-existenceMehmet C Yildirim, Ahmet Talha Kansizoglu, Sinan Emre, et al.The Review of Scientific Instruments|July 3, 2020
Radiation furnace for synchrotron dark-field x-ray microscopy experimentsC Yildirim, H Vitoux, L E Dresselhaus-Marais, et al.Brain & Spine|December 26, 2025
Stereotactic radiosurgery for intracranial Langerhans cell histiocytosis: A multi-institutional case series with long-term follow-upAli H Duzkalir, Dogu C Yildirim, Timoteo Almeida, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 21, 2021
The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapyDeniz C Guven, Gozde Kavgaci, Oktay H Aktepe, et al.Clinical and Experimental Rheumatology|August 11, 2004
The association of milk consumption with the occurrence of symptomatic knee osteoarthritisC Kaçar, E Gilgil, T Tuncer, et al.Rheumatology International|December 9, 2003
The prevalence of symptomatic knee and distal interphalangeal joint osteoarthritis in the urban population of Antalya, TurkeyC Kaçar, E Gilgil, S Urhan, et al.Clinical Rheumatology|June 9, 2005
Prevalence of rheumatoid arthritis in Antalya, TurkeyC Kaçar, E Gilgil, T Tuncer, et al.International Journal of Environmental Research and Public Health|April 3, 2021
Different Doses of Carbohydrate Mouth Rinse Have No Effect on Exercise Performance in Resistance Trained WomenRaci Karayigit, Scott C Forbes, Alireza Naderi, et al.Biomarkers in Medicine|June 13, 2023
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancerFatih Kus, Deniz C Guven, Hasan C Yildirim, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 15, 2021
PILE: a candidate prognostic score in cancer patients treated with immunotherapyD C Guven, H C Yildirim, E Bilgin, et al.Pageof 7